Trevi Therapeutics News

Trevi Therapeutics | 10-Q: Quarterly report

May 7 16:17 ET

Trevi Therapeutics | 8-K: Trevi Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates

May 7 16:11 ET

Trevi Therapeutics | ARS: Annual Report to Security Holders

Apr 29 14:16 ET

Trevi Therapeutics | DEFA14A: Others

Apr 26 16:50 ET

Trevi Therapeutics | DEF 14A: Definitive information statements

Apr 26 16:45 ET

Trevi Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Rosalind Advisors, Inc.(1.34%),Steven Salamon(1.34%), etc.

Apr 25 19:41 ET

Trevi Therapeutics | 8-K: Trevi Therapeutics Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Updates

Mar 20 16:16 ET

Trevi Therapeutics | 10-K: Annual report

Mar 20 16:14 ET

Trevi Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 20 16:13 ET

Trevi Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Simon Farrell

Feb 16 16:48 ET

Trevi Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Galletta Christopher

Feb 16 16:48 ET

Trevi Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Clark David J

Feb 16 16:47 ET

Trevi Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer GOOD JENNIFER L

Feb 16 16:47 ET

Trevi Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer SCIASCIA THOMAS

Feb 16 16:47 ET

Trevi Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Delfini Lisa

Feb 16 16:47 ET

Trevi Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Venrock Healthcare Capital Partners II, L.P.(9.99%),VHCP Co-Investment Holdings II, LLC(9.99%), etc.

Feb 14 20:48 ET

Trevi Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Fairmount Funds Management LLC(0.0%),Peter Harwin(0.0%), etc.

Feb 14 15:55 ET

Trevi Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Viking Global Investors LP(9.99%),Viking Global Opportunities Parent GP LLC(9.99%), etc.

Feb 14 10:27 ET

Trevi Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Rubric Capital Management LP(8.90%),David Rosen(8.90%)

Feb 12 07:07 ET

Trevi Therapeutics: Q3 2023 Earnings Report

Nov 9, 2023 16:13 ET